Get informed when a big investor buys or sells
+ FollowLoading insider trades…
Loading congress trades…
| Market cap | $20,182.00 |
|---|---|
| Enterprise Value | $-4,533,818.00 |
| Earnings per Share | $-0.01 |
| Beta | 7.41 |
| Outstanding Shares | 201,817,000 |
| P/E Ratio | -0.23 |
|---|---|
| PEG | 7.43 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 0.28 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
Synairgen plc is a biopharmaceutical company focused on the discovery and advancement of therapeutic drugs for various respiratory conditions. Their product pipeline features SNG001, an inhaled interferon beta under development for the t...